Karyopharm Therapeutics Inc.KPTINASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank64
3Y CAGR-7.5%
5Y CAGR-3.3%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-7.5%/yr
vs +9.2%/yr prior
5Y CAGR
-3.3%/yr
Recent deceleration
Acceleration
-16.7pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$236.77M-10.5%
2024$264.68M-4.0%
2023$275.57M-7.9%
2022$299.28M-2.9%
2021$308.09M+10.1%
2020$279.94M+21.6%
2019$230.17M+9.5%
2018$210.22M+59.1%
2017$132.14M+19.2%
2016$110.89M-